4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-028864
CEO and CFO bought 1,500 shares at $15.89 ($23,835)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2024-07-23 | Purchase | +1,500 | $15.89 | $23,835 | 5,527,102 | D |
| Open-market purchases · 1,500 sh · avg $15.89 · $23,835 | |||||||
Loading xslF345X05/ownership.xml…